logo

Novartis Ag (NVS)



Trade NVS now with
  Date
  Headline
9/22/2018 2:03:21 PM Novartis To File For New Lucentis Indication In Retinopathy Of Prematurity
9/22/2018 2:02:24 PM Novartis Reports New Analysis Of Phase III Brolucizumab Data Reinforces Superior Reduction Of Retinal Fluid
9/21/2018 7:29:12 AM Sandoz Reports Positive CHMP Opinion For Proposed Biosimilar Pegfilgrastim
9/21/2018 7:28:32 AM Novartis Announces Positive CHMP Opinion For One-time Gene Therapy Luxturna
9/21/2018 7:27:51 AM Novartis Receives Positive CHMP Opinion For Gilenya For Multiple sclerosis
9/17/2018 1:17:40 AM Novartis Unveils Alcon Experience Academy Reinforces Commitment To Training And Education For Eye Care Professionals
9/13/2018 1:22:17 AM Novartis: Real-world Evidence Confirms Efficacy, Safety Benefits Of Cosentyx
9/12/2018 1:16:39 AM Novartis: Survey Show Psoriasis Patients Want Treatment Effect Beyond Clear Skin
9/11/2018 1:02:20 AM Alcon Plans To Locate Its Future Global Headquarters In Switzerland
9/6/2018 12:33:52 AM Novartis To Divest Sandoz US Dermatology Business And Generic US Oral Solids Portfolio To Aurobindo
8/29/2018 1:25:45 AM Novartis Says EC Approves Tafinlar In Combination With Mekinist
8/29/2018 1:02:02 AM Alcon Announces Voluntary Global Market Withdrawal Of CyPass Micro-Stent For Surgical Glaucoma